“Pricing and Reimbursement for Pharmaceuticals” Educational Workshop Took Place on February 22nd at Hilton Habtoor Grand Hotel

LSPOR is the Lebanon chapter of ISPOR, the leading International Society for Pharmaco economics and Outcomes Research. ISPOR was founded in 1995 as an international multidisciplinary professional membership society. Its mission and vision is to advance the policy, science, and practice of Pharmaco- economics (health economics) and outcomes research, encouraging the efficiency, effectiveness, and fairness of health care to improve health. The Lebanon chapter obtained legal recognition as a local NGO in June 2015. Our goal is to “Educate, Engage and Inspire Leaders to Improve Health” and I am extremely honored to be serving as ISPOR Lebanese Chapter President for the upcoming year.

Providing efficient and effective health care is a global challenge. LSPOR is a not for profit organization that exists to help meet this challenge at a local level by working together with local payers, demanding greater evidence of value; and helping to establish evidence-based decision making, with the ultimate goal to achieve universal health coverage and equity for Lebanese population. It is also the Platform for Member Engagement, Dialogue with Decision Makers, Education and Information Sharing as well as Networking between outcome researchers, health technology developers and assessors, regulators, health economists, health care policy makers, payers, providers, patients, populations, and society as a whole.

Meeting Objectives:

The goal of this workshop is to describe the health system and the different health coverage schemes in our region compared to reference countries. It will introduce the structure of reimbursement bodies (public and private) and the health services funding categories. Additionally, we aim to shed the light on the legislation and main task of the health coverage funds and to discuss the financing of the health services, the risk pooling, the sources of funding, the financing intermediaries, the distribution among providers and the basis of health products pricing. Leading international experts along with local key opinion leaders will share the latest updates in the field of pricing and reimbursement during interactive sessions and workshops.

Target Audience :

  • Policy Makers
  • Regulators
  • Researchers
  • Academicians
  • Payers and Decision Makers from public and private sectors
  • Pharmaceutical and Biotech companies
  • Consultancy firms


Presentation: Pricing and Reimbursement Policies Looking Forward in Europe

Presentation: Pricing and Market Access Challenges for Payers in Europe

Presentation: Value Based Pricing and Innovation across Europe and Beyond

Photo Gallery:

Video Highlights: